This approach exhibited the production of enzymes with three- to eightfold higher catalytic efficiencies [80].
In particular, this approach exhibits good advantages when some 1D nanostructures might be difficult or impossible to synthesize directly.
However, this approach exhibits several apparent weaknesses, such as single point of failure, performance bottlenecks, and serious security threats.
Molecules developed from this approach exhibited high affinity and selectivity for the D3 receptor as judged from preliminary [3H]spiperone binding data.
This approach exhibited a throughput that was 5 to 20 times higher and a sample and reagent usage that was approximately 50-100 times lower than conventional assays.
One clone, called "C60", that was isolated in this approach exhibited a significant DNA sequence similarity with a mouse EST sequence present in the EMBL/GenBank database (clone MNCb-0941, AU035837n #: AU035837) [ 1].
This approach exhibits the capability of detecting antitumor drug which caused slight variation of the cells through the trapping efficiency value, with advantages of more convenient, microscale, label-free, and real time detection than traditional methods.
However, by ignoring this assumption we gain much speed, and our simulation studies indicate that the approach exhibits reasonable power to detect QTL in many situations.
In fact, the approach exhibits a size that is independent of the number of receivers.
